Earnings Per Share, Basic of Co-Diagnostics, Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Co-Diagnostics, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Co-Diagnostics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.16, a 50% increase year-over-year.
  • Co-Diagnostics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 0, a 28% increase year-over-year.
  • Co-Diagnostics, Inc. annual Earnings Per Share, Basic for 2024 was -1.24, a 3.3% decline from 2023.
  • Co-Diagnostics, Inc. annual Earnings Per Share, Basic for 2023 was -1.2, a 167% decline from 2022.
  • Co-Diagnostics, Inc. annual Earnings Per Share, Basic for 2022 was -0.45, a 135% decline from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Co-Diagnostics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 0 -0.16 +0.16 +50% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 -1 -0.23 +0.02 +8% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 -1 -0.24 +0.07 +23% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 -1 -0.36 +0.13 +27% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 -1 -0.32 -0.12 -60% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 -1 -0.25 +0.06 +19% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 -1 -0.31 -0.11 -55% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 -1 -0.49 +0.19 +28% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 -1 -0.2 -0.16 -400% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 -1 -0.31 -0.23 -288% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 -1 -0.2 -0.55 -157% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 0 -0.68 -0.93 -372% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 0 -0.04 -0.44 -110% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 0 -0.08 -0.42 -124% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 1 0.35 +0.07 +25% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 1 0.25 -0.29 -54% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 1 0.4 -0.16 -29% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 1 0.34 -0.2 -37% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 1 0.28 +0.33 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 1 0.54 01 Oct 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 0.56 +0.66 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 0.54 +0.62 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 -0.05 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q3 2019 -0.1 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 -0.08 01 Apr 2019 30 Jun 2019 10-Q/A 03 Nov 2020 2020 Q2

Co-Diagnostics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -1.24 -0.04 -3.3% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 -1.2 -0.75 -167% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 -0.45 -1.72 -135% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 1.27 -0.32 -20% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 1.59 +1.96 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
2019 -0.37 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.